CAV3 Polyclonal Antibody

Elabscience
Product Code: E-AB-13049
Product Group: Primary Antibodies
Supplier: Elabscience
CodeSizePrice
E-AB-13049-20uL20uL£125.00
Quantity:
E-AB-13049-60uL60uL£172.00
Quantity:
E-AB-13049-120uL120uL£237.00
Quantity:
E-AB-13049-200uL200uL£344.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rabbit
Antibody Isotype: IgG
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species: Human
Applications:
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Immunohistochemistry (IHC)
  • Western Blot (WB)
Shipping:
Ice packs
Storage:
-20°C

Images

1 / 3
Western Blot analysis of Human fetal muscle tissue using CAV3 Polyclonal Antibody at dilution of 1:500
2 / 3
Immunohistochemistry of paraffin-embedded Human gastic cancer using CAV3 Polyclonal Antibody at dilution of 1:30
3 / 3
Immunohistochemistry of paraffin-embedded Human lymphoma using CAV3 Polyclonal Antibody at dilution of 1:30

Western Blot analysis of Human fetal muscle tissue using CAV3 Polyclonal Antibody at dilution of 1:500
Immunohistochemistry of paraffin-embedded Human gastic cancer using CAV3 Polyclonal Antibody at dilution of 1:30
Immunohistochemistry of paraffin-embedded Human lymphoma using CAV3 Polyclonal Antibody at dilution of 1:30

Documents

Further Information

Abbreviation:
CAV3
Background:
This gene encodes a caveolin family member, which functions as a component of the caveolae plasma membranes found in most cell types. Caveolin proteins are proposed to be scaffolding proteins for organizing and concentrating certain caveolin-interacting molecules. Mutations identified in this gene lead to interference with protein oligomerization or intra-cellular routing, disrupting caveolae formation and resulting in Limb-Girdle muscular dystrophy type-1C (LGMD-1C), hyperCKemia or rippling muscle disease (RMD). Alternative splicing has been identified for this locus, with inclusion or exclusion of a differentially spliced intron. In addition, transcripts utilize multiple polyA sites and contain two potential translation initiation sites.
Buffer:
PBS with 0.05% sodium azide and 50% glycerol, PH7.4
Calculated MW:
17kDa
Concentration:
0.2 mg/mL
Conjugation:
Unconjugated
Dilution:
WB 1:500-1:2000, IHC 1:25-1:100
Immunogen:
Synthetic peptide of human CAV3
Purification method:
Affinity purification
Target Synonym:
CAV3;CAV3;Caveolin 3;Caveolin-3;LGMD1C;LQT9;M-caveolin;MGC126100;MGC126101;MGC126129;OTTHUMP00000115603;OTTHUMP00000207105;VIP 21;VIP21
UNIProt ID:
P56539